HuGE Literature Finder
Records
1
-
6
Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma. International journal of genomics 2022 2022 3342666. Guo Ya, Zhang Yin Bin, Li Yi, Su Wang Hui, He Shan, Pan Shu Pei, Xu Kun, Kou Wei H |
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy. International journal of cancer 2020 May . Haakensen Vilde D, Khadse Anand, Sandhu Vandana, Halvorsen Ann Rita, Solberg Steinar K, Jørgensen Lars H, Brustugun Odd Terje, Kure Elin H, Helland Åsla |
The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes. Mutagenesis 2019 Jun . Wang Na, Li Yan, Zhou Rong-Miao, Cui Sai-Jin, Cao Shi-Ru, Huang Xi, Huo Xiang-Ran, Shan Bao- |
Variants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma. BioMed research international 2015 2015 860405. Po?piech Ewelina, Lig?za Janusz, Wilk Wac?aw, Go?as Aniela, Jaszczy?ski Janusz, Stelmach Andrzej, Ry? Janusz, Blecharczyk Aleksandra, Wojas-Pelc Anna, Jura Jolanta, Branicki Wojcie |
Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population. Molecular biology reports 2013 Aug 40 (8): 4819-26. Marques Inês, Teixeira Ana L, Ferreira Marta, Assis Joana, Lobo Francisco, Maurício Joaquina, Medeiros R |
Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese. PloS one 2011 6 (2): e16748. Ma Fuchao, Zhang Hongxing, Zhai Yun, Huang Wenfeng, Zhao Chang, Ou Shengqiu, Zhou Hong, Yuan Wenzhao, Wang Zhifu, Wang Hongxue, Yue Wei, Yu Lixia, Li Peiyao, Xia Xia, Cai Mi, Zhang Yang, Cui Ying, He Fuchu, Ma Yilong, Zhou Gangqi |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: